Guest guest Posted April 2, 2005 Report Share Posted April 2, 2005 I wonder what the time frame on this and when they think they can sell it to the public. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 2, 2005 Report Share Posted April 2, 2005 Curis Achieves Milestone under Wyeth Collaboration CAMBRIDGE, MA , March 23, 2005 – Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company, today announced that it has achieved a development milestone under a collaboration with one of its corporate partners, Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE). The milestone is based on Wyeth's and Curis' continued progress in preclinical development of Hedgehog pathway agonists for the treatment of stroke, neurological and other disorders. The milestone will trigger a modest payment from Wyeth to Curis in accordance with the terms of their 2004 agreement. The Hedgehog signaling pathway regulates the normal development of the brain and spinal cord. Wyeth and Curis are collaborating to develop several promising small molecule agonist compounds that can activate the Hedgehog signaling pathway and thereby promote nervous system repair. Many of these small molecules are orally available and can enter into the brain and spinal cord, thus making them an attractive new class of drug development candidates for neurological disorders. Passeri, President and Chief Executive Officer of Curis, said, " We are very pleased with the progress that has been made with Wyeth in the Hedgehog agonist program. The achievement of this milestone is an important next step in the path of bringing these promising drug candidates towards clinical trials and ultimately to the patients who need them. " Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.